Abstract

mTORC1 senses nutrients and growth factors and phosphorylates downstream targets, including the transcription factor TFEB, to coordinate metabolic supply and demand. These functions position mTORC1 as a central controller of cellular homeostasis, but the behavior of this system in individual cells has not been well characterized. Here, we provide measurements necessary to refine quantitative models for mTORC1 as a metabolic controller. We developed a series of fluorescent protein-TFEB fusions and a multiplexed immunofluorescence approach to investigate how combinations of stimuli jointly regulate mTORC1 signaling at the single-cell level. Live imaging of individual MCF10A cells confirmed that mTORC1-TFEB signaling responds continuously to individual, sequential, or simultaneous treatment with amino acids and the growth factor insulin. Under physiologically relevant concentrations of amino acids, we observe correlated fluctuations in TFEB, AMPK, and AKT signaling that indicate continuous activity adjustments to nutrient availability. Using partial least squares regression modeling, we show that these continuous gradations are connected to protein synthesis rate via a distributed network of mTORC1 effectors, providing quantitative support for the qualitative model of mTORC1 as a homeostatic controller and clarifying its functional behavior within individual cells.

Data availability

The following files contain the per-cell fluorescence intensity data, extracted from microscope image data, that were used to generate each figure in the paper:Sparta2023_Figure1_SourceData1.xlsSparta2023_Figure1_SourceData2.xlsSparta2023_Figure2_SourceData1.xlsxSparta2023_Figure3_SourceData1.xlsSparta2023_Figure4_SourceData1.xlsxSparta2023_Figure4_SourceData2.xlsxSparta2023_Figure4_SourceData3.xlsxSparta2023_Figure4_SourceData4.xlsxSparta2023_Figure4_SourceData5.xlsxSparta2023_Figure4_SourceData6.xlsxSparta2023_Figure5_SourceData1.xlsxSparta2023_Figure5_SourceData2.xlsxSparta2023_Figure5_SourceData3.xlsxSparta2023_Figure5_SourceData4.xlsxSparta2023_Figure6_SourceData1.xlsx

Article and author information

Author details

  1. Breanne Sparta

    Department of Molecular and Cellular Biology, University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  2. Nont Kosaisawe

    Department of Molecular and Cellular Biology, University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  3. Michael Pargett

    Department of Molecular and Cellular Biology, University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  4. Madhura Patankar

    Department of Molecular and Cellular Biology, University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  5. Nicholaus DeCuzzi

    Department of Molecular and Cellular Biology, University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  6. John G Albeck

    Department of Molecular and Cellular Biology, University of California, Davis, Davis, United States
    For correspondence
    jgalbeck@ucdavis.edu
    Competing interests
    John G Albeck, John Albeck has received research grants from Kirin Corporation..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2688-8653

Funding

National Institute of General Medical Sciences (R35GM139621)

  • John G Albeck

National Institute of General Medical Sciences (R01GM115650)

  • John G Albeck

National Science Foundation (2136040)

  • John G Albeck

National Heart, Lung, and Blood Institute (T32HL007013)

  • Nicholaus DeCuzzi

National Institute of General Medical Sciences (F31GM120937)

  • Breanne Sparta

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Sparta et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,025
    views
  • 291
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Breanne Sparta
  2. Nont Kosaisawe
  3. Michael Pargett
  4. Madhura Patankar
  5. Nicholaus DeCuzzi
  6. John G Albeck
(2023)
Continuous sensing of nutrients and growth factors by the mTORC1-TFEB axis
eLife 12:e74903.
https://doi.org/10.7554/eLife.74903

Share this article

https://doi.org/10.7554/eLife.74903

Further reading

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.